The contributions of Jeff Aronin in Pharmaceuticals

Health is a significant factor in improving people’s lives. The number of illnesses without adequate treatments are becoming the most significant challenges facing medical professionals today. This is the reason behind Jeff Aronin establishing Paragon Bioscience. For more than two decades, Jeff has been at the top of the game in biotech and health. As the CEO and Chairman of Paragon Bioscience, Jeff Aronin has applied his entrepreneurial energy and expertise in the industry to build an incubator and a leading investor of biotech companies. His passion for helping patients is what drove him for science. Having seen how magical the pharmaceuticals were doing, Jeff Aronin founded Ovation Pharmaceuticals Inc. in the year 2000. The success of his company was deeply rooted in his ability to understand the need of a patient, recognizing promising science, and focusing his team on getting the medicine approved.

 

Jeff Aronin has been on the front line addressing the unfulfilled needs of those suffering from the rare diseases. His scientific visionary and entrepreneurial work are some of the things that have largely contributed to a dozen of technologies and new medicines being developed and approved. Jeff has been privileged to serve as a chairman in some life science companies that include, Castle Creek Pharmaceuticals, Harmony Biosciences, and Paragon Pharmaceuticals. His level of success can be matched to a limited number of those operating in the same industry. Jeff Aronin is very kind to share his perspective with those seeking growth in healthcare.

 

At paragon Bioscience, the cause of a given condition or disease is first identified to get a better outcome. The next thing that the team does is to determine the science with the best treatment. Development and research of medicine are one of the risky businesses in existence as it can lead to loss of lives. Many of the procedures might seem promising during the trial phase of the research only to end up failing. Despite this, Jeff Aronin and his team remain focused on developing medicines and illnesses that need treatment most. By clinging to its core values and missions, Jeff believes that the company will realize its goals by applying these innovative treatments.